Cooper Companies (NASDAQ:COO) Given New $78.00 Price Target at JPMorgan Chase & Co.

by · The Cerbat Gem

Cooper Companies (NASDAQ:COO – Free Report) had its target price upped by JPMorgan Chase & Co. from $66.00 to $78.00 in a research report report published on Friday morning,Benzinga reports. They currently have a neutral rating on the medical device company’s stock.

Other equities research analysts have also recently issued reports about the stock. Stifel Nicolaus set a $95.00 price target on shares of Cooper Companies and gave the stock a “buy” rating in a research report on Friday. Mizuho set a $100.00 target price on Cooper Companies and gave the stock an “outperform” rating in a report on Friday. Needham & Company LLC restated a “buy” rating and issued a $100.00 price target (up from $94.00) on shares of Cooper Companies in a research note on Friday. Barclays initiated coverage on Cooper Companies in a research report on Monday, October 13th. They set an “overweight” rating and a $85.00 price target on the stock. Finally, Piper Sandler reissued an “overweight” rating and issued a $94.00 price objective (up previously from $83.00) on shares of Cooper Companies in a report on Friday. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $90.31.

Check Out Our Latest Stock Report on Cooper Companies

Cooper Companies Trading Up 5.7%

NASDAQ:COO opened at $81.40 on Friday. The company has a market cap of $16.18 billion, a P/E ratio of 43.30, a price-to-earnings-growth ratio of 1.89 and a beta of 1.05. Cooper Companies has a twelve month low of $61.78 and a twelve month high of $101.53. The business has a 50 day moving average price of $72.29 and a two-hundred day moving average price of $71.74. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29.

Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.01%. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the previous year, the firm posted $1.04 earnings per share. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, analysts expect that Cooper Companies will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its board has initiated a stock repurchase plan on Wednesday, September 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

Insider Activity at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius bought 2,000 shares of the firm’s stock in a transaction that occurred on Monday, September 29th. The shares were acquired at an average cost of $68.39 per share, with a total value of $136,780.00. Following the acquisition, the director owned 5,777 shares of the company’s stock, valued at $395,089.03. The trade was a 52.95% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.98% of the company’s stock.

Hedge Funds Weigh In On Cooper Companies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC grew its stake in shares of Cooper Companies by 5.1% in the second quarter. Janney Montgomery Scott LLC now owns 97,394 shares of the medical device company’s stock valued at $6,931,000 after acquiring an additional 4,761 shares in the last quarter. United Services Automobile Association acquired a new stake in Cooper Companies in the 1st quarter worth about $414,000. Ruffer LLP bought a new stake in Cooper Companies in the 2nd quarter valued at about $17,624,000. Asset Management One Co. Ltd. grew its position in shares of Cooper Companies by 3.2% during the 2nd quarter. Asset Management One Co. Ltd. now owns 88,313 shares of the medical device company’s stock worth $6,284,000 after purchasing an additional 2,746 shares in the last quarter. Finally, Amica Mutual Insurance Co. bought a new position in shares of Cooper Companies during the second quarter worth approximately $1,060,000. 24.39% of the stock is owned by institutional investors.

About Cooper Companies

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

See Also